A New King of The GLP-1s Could Be Crowned – Cardiac Wire

A New King of The GLP-1s Could Be Crowned  Cardiac Wire‘Godzilla’ of weight-loss drugs could provide other important health benefits  The GuardianWhy Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s  CNBCBlockbuster retatrutide trial signals a ‘new high-water mark’ for weight-loss drugs  Scientific AmericanOzempic Rival Delivers 25% Weight Loss at Highest Dose in Phase 3 Trial  ScienceAlert